NCT04380597View on ClinicalTrials.gov

Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 26, 2019

Primary Completion Date

December 15, 2019

Study Completion Date

July 30, 2021

Conditions
Nail Psoriasis
Interventions
DRUG

Calcipotriene and betamethasone dipropionate aerosol foam

Prescribed according to clinical practice and following Product Data Sheet instructions

Trial Locations (1)

36001

Complejo Hospitalario Universitario de Pontevedra, Pontevedra

All Listed Sponsors
lead

Angeles Florez

OTHER

NCT04380597 - Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life | Biotech Hunter | Biotech Hunter